BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  IN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases

  March 4, 2025

   · 

  8 min read
• Press Releases

  Sernova Biotherapeutics Receives FDA Clearance for IND Application for its Cell Pouch Bio-hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism

  March 4, 2025

   · 

  3 min read
• Press Releases

  Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2024 Financial Results

  March 4, 2025

   · 

  12 min read
• Press Releases

  Apogee Therapeutics Announces Positive Interim Phase 1 Results from the APG990 Healthy Volunteer Trial, Unlocking Potential Maintenance Dosing Every Three and Six Months for APG279 (APG777 + APG990)

  March 4, 2025

   · 

  9 min read
• Press Releases

  IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets

  March 4, 2025

   · 

  4 min read
• Press Releases

  Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

  March 4, 2025

   · 

  7 min read
• Press Releases

  Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance

  March 4, 2025

   · 

  19 min read
• Press Releases

  Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

  March 4, 2025

   · 

  10 min read
• Press Releases

  Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease

  March 4, 2025

   · 

  8 min read
• Press Releases

  Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

  March 4, 2025

   · 

  11 min read